1. Field of the Invention
The present invention pertains to medical equipment, and more particularly, to a therapeutic ultrasound system for ablating obstructions within tubular anatomical structures such as blood vessels.
2. Description of the Prior Art
A number of ultrasound systems and devices have heretofore been proposed for use in ablating or removing obstructive material from blood vessels. However, all of these systems and devices generally encounter three types of problems which are not always adequately addressed by these systems and devices.
One type of problem relates generally to the effective transmission of ultrasound energy from an ultrasound source to the distal tip of the device where the ultrasound energy is applied to ablate or remove obstructive material. Since the ultrasound source, such as a transducer, is usually located outside the human body, it is necessary to deliver the ultrasound energy over a long distance, such as about 150 cm, along an ultrasound transmission wire from the source to the distal tip. Attenuation of the acoustical energy along the length of the transmission wire means that the energy reaching the distal tip is reduced. To ensure that sufficient energy reaches the distal tip, a greater amount of energy must be delivered along the transmission wire from the source to the distal tip. This transmission of increased energy along the transmission wire may increase the fatigue experienced by the transmission wire at certain critical locations, such as at the connection between the transducer and the transmission wire. This fatigue and any associated stress may cause the transmission wire to break.
In this regard, the size of the proximal end of the transmission wire cannot be large. The proximal end of the transmission wire is usually bent while moving the ultrasound catheter back and forth during interventional procedures. A larger proximal end for a transmission wire will cause higher attenuation than a smaller proximal end, and provides a larger mass to expand and contract during the delivery of ultrasound energy.
Another type of problem relates to the heat that is built up from the transmission of ultrasound energy along the transmission wire. Many ultrasound transmission wires are made of superelastic alloys which exhibit elasticity within a specific temperature range, usually between 10 degrees Celsius and 50 degrees Celsius. However, during the delivery of ultrasound energy, the temperature of the transmission wire may reach 100 to 200 degrees Celsius, at which the transmission wire may lose its superelasticity and may experience mechanical deformations at portions that are bent when exposed to the high temperatures. The high temperatures may also cause the propagated energy to be lost more rapidly and transferred to heat, thereby reducing the efficacy of the ultrasound transmission wire.
Conventional ultrasound systems typically infuse a coolant fluid (usually 0.9% NaCl solution) through the irrigation lumen of an ultrasound catheter to bathe the transmission wire. To maintain the transmission wire within the desired temperature range of 10-50 degrees Celsius, the irrigation rate of the coolant fluid needs to be dramatically increased. However, there are two limitations to this approach. First, endovascular catheters usually have small inner and outer diameters that range between 0.5 to 3 mm. Therefore, the volume of fluid that can be delivered through the catheter is relatively small. Second, there is a limit to the amount of irrigant that can be delivered and left in the body of the patient during any interventional procedure, and this amount of irrigant should not exceed 500-1,000 cm3. In addition to these two limitations, increased irrigation fluid pressure may cause local tissue damage.
Thus, there still exists a need in the art for improved ultrasound systems having ultrasound devices or catheters which address the aforementioned problems.
It is an object of the present invention to provide an improved transmission wire for an ultrasound device.
It is another object of the present invention to provide an improved way of cooling the transmission wire of an ultrasound device during an interventional procedure.
In order to accomplish the objects of the present invention, there is provided an ultrasound system having a catheter including an elongate flexible catheter body having at least one lumen extending longitudinally therethrough. An ultrasound transmission wire extends longitudinally through the lumen of the catheter body, and has a proximal region, a distal region, and an intermediate region between the proximal region and the distal region. A sonic connector is connected to the proximal region of the ultrasound transmission wire, and a distal head is positioned at the distal end of the catheter body and coupled to the distal region of the ultrasound transmission wire. The proximal region of the ultrasound transmission wire has a larger diameter than the intermediate region, the intermediate region is continuously tapered with a progressively decreasing diameter from its proximal end to its distal end, and the distal region has a greater diameter than the distal end of the intermediate region.
The present invention also discloses a method for disrupting an occlusion in a blood vessel, which includes positioning an ultrasound catheter in a blood vessel such that a distal end of the catheter is adjacent an occlusion, introducing refrigerated irrigation fluid through the catheter, and transmitting ultrasound energy through the ultrasound catheter to disrupt the occlusion into multiple occlusion fragments.
The present invention also discloses a method for disrupting an occlusion in a blood vessel, which includes positioning an ultrasound catheter in a blood vessel such that a distal end of the catheter is adjacent the occlusion, transmitting ultrasound energy through the ultrasound catheter to disrupt the occlusion into multiple occlusion fragments, and introducing microbubbles around the distal end of the catheter during the transmission of ultrasound energy.
The following detailed description is of the best presently contemplated modes of carrying out the invention. This description is not to be taken in a limiting sense, but is made merely for the purpose of illustrating general principles of embodiments of the invention. The scope of the invention is best defined by the appended claims.
In certain instances, detailed descriptions of well-known devices, compositions, components, mechanisms and methods are omitted so as to not obscure the description of the present invention with unnecessary detail.
The catheter body 12 is formed of a flexible polymeric material such as nylon (Pebax™) manufactured by Atochimie, Cour be Voie, Hauts Ve-Sine, France. The flexible catheter body 12 is preferably in the form of an elongate tube having one or more lumens extending longitudinally therethrough. The catheter body 12 defines a main lumen 40. Extending longitudinally through the main lumen 40 is an elongate ultrasound transmission wire 42 having a proximal end which is removably connectable to the ultrasound transducer 24 via a sonic connector 76 (described below in connection with
A distal head 44 is affixed to the distal end 16 of the catheter body 12. In the embodiments shown, the distal head 44 has a generally blunt distal tip 46, and has a proximal portion 48 whose outer diameter is slightly less than the largest outer diameter of the distal head 44, so as to define an annular shoulder 50 that is placed in the open distal end of the catheter body 12 such that the proximal portion 48 of the distal head 44 is received inside the catheter body 12 in a manner where the outer surface of the catheter body 12 is flush with the outer surface of the distal head 44.
A guidewire port 58 is provided in the catheter body 12 at a location that is about 0.1 cm to 30 cm from the distal head 44. A guidewire lumen 60 extends from the guidewire port 58 through a bore 62 in the distal head 44 to a guidewire exit 64 at the tip 46 of the distal head 44.
The distal head 44 is preferably formed of a material that is rigid, is radio- dense, and has low-density. A material having such characteristics is desirable because the ultrasound energy that is delivered from a transducer 24 to the distal head 44 via the ultrasound transmission member 42 goes through severe bends in the patient's vasculature. These bends significantly impact the displacement at the distal head 44 and its ability to ablate atherosclerotic plaque. The distal head 44 provides an additional load so that a heavier distal head 44 will cause lower displacements. As a result, a distal head 44 made of a material that is rigid, is radio-dense, and which has low-density will improve the effectiveness of the ablation. As a non-limiting example, the material should have an average density that does not exceed 5 g/cm3, or where the total mass of the distal head 44 does not exceed 0.015 grams.
As for the desired materials for the distal head 44, titanium alloys are preferable because they have the highest strength-to-weight ratios of any structural metals, and are corrosion resistant and biocompatible. Pure titanium has a density of 0.163 lb/in3. Examples of desirable alloy elements for use with Titanium include Aluminum and Vanadium, such as in Ti-6AI-4V, which has tensile yield strength in the range of 130-150 ksi.
Although pure Aluminum is relatively weak, alloying with various elements yields significant strength improvements with minimal sacrifice in density. Pure Aluminum has a density of 0.097 lb/in3. Examples of desirable alloying elements for Aluminum include Manganese, Silicon, and/or Magnesium, such as in 3, 4, 5 and 6 series Aluminum alloys. Tensile yield strengths of these common alloys range from 10-50 ksi.
Magnesium alloys are also preferable because they are extremely light, stable, abundant, and easy to machine. They have high specific strength and rigidity, with a very low density range of 0.064-0.066 lb/in3, and UTS range of 22-55 ksi. Examples of desirable alloying elements that can be used with Magnesium include Aluminum and Zinc, such as in AZ31B for machined tips.
The ultrasound transmission wire 42 extends through the lumen 40, and is inserted into a bore 52 which extends longitudinally into the proximal portion 48 of the distal head 44. The distal end of the ultrasound transmission wire 42 is firmly held within the bore 52 by the frictional engagement thereof to the surrounding material of the distal head 44, or by other mechanical or chemical affixation means such as but not limited to weldments, adhesive, soldering and crimping. Firm affixation of the ultrasound transmission wire 42 to the distal head 44 serves to facilitate direct transmission of the quanta of ultrasonic energy passing through the ultrasound transmission wire 42 to the distal head 44. As a result, the distal head 44 and the distal end 16 of the catheter device 10 are caused to undergo ultrasonic vibration in accordance with the combined quanta of ultrasonic energy being transmitted through the ultrasound transmission wire 42.
In the preferred embodiment, the ultrasound transmission wire 42 may be formed of any material capable of effectively transmitting the ultrasonic energy from the ultrasound transducer 24 to the distal head 44, including but not necessarily limited to metal, plastic, hard rubber, ceramic, fiber optics, crystal, polymers, and/or composites thereof. In accordance with one aspect of the invention, all or a portion of the ultrasound transmission wire 42 may be formed of one or more materials which exhibit super-elasticity. Such materials should preferably exhibit super- elasticity consistently within the range of temperatures normally encountered by the ultrasound transmission wire 42 during operation of the catheter device 10. Specifically, all or part of the ultrasound transmission wire 42 may be formed of one or more metal alloys known as “shape memory alloys”.
Examples of super-elastic metal alloys which are usable to form the ultrasound transmission wire 42 of the present invention are described in detail in U.S. Pat. No. 4,665,906 (Jervis); U.S. Pat. No. 4,565,589 (Harrison); U.S. Pat. No. 4,505,767 (Quin); and U.S. Pat. No. 4,337,090 (Harrison). The disclosures of U.S. Pat. Nos. 4,665,906; 4,565,589; 4,505,767; and 4,337,090 are expressly incorporated herein by reference insofar as they describe the compositions, properties, chemistries, and behavior of specific metal alloys which are super-elastic within the temperature range at which the ultrasound transmission wire 42 of the present invention operates, any and all of which super-elastic metal alloys may be usable to form the super-elastic ultrasound transmission wire 42.
The frontal portion of the Y-connector 18 is connected to the proximal end 14 of the catheter 10 using techniques that are well-known in the catheter art. An injection pump 54 or IV bag (not shown) or syringe (not shown) can be connected, by way of an infusion tube 55, to an infusion port or sidearm 72 of the Y-connector 18 (see
According to one embodiment of the present invention, the coolant fluid is preferably a refrigerated coolant fluid, preferably saline 0.9% NaCl. The refrigerated coolant fluid will be stored in a refrigerator or similar cooling unit at a temperature between 4 and 20 degrees Celsius (or between 40-72 degrees Fahrenheit) prior to use. The use of a low-temperature coolant fluid will be effective in maintaining the transmission wire 42 within the desired temperature range of 10-50 degrees Celsius. The refrigerated coolant fluid can be flowed through the main lumen 40 and exit the catheter body 12 via irrigation outlets 56 (see
In addition to the foregoing, the injection pump 54 or syringe may be utilized to infuse a radiographic contrast medium into the catheter 10 for purposes of imaging, as described in greater detail below. Examples of iodinated radiographic contrast media which may be selectively infused into the catheter 10 via the injection pump are commercially available as Angiovist 370 from Berlex Labs, Wayne, N.J. and Hexabrix from Malinkrodt, St. Louis, Mo.
The proximal end of the Y-connector 18 is attached to the distal end of the catheter knob 20 by threadably engaging the proximal end of the Y-connector 18 inside a threaded distal bore (not shown) at the distal end of the catheter knob 20.
Referring also to
The sonic connector 76 is housed inside the proximal bore 84 of the catheter knob 20. The proximal bore 84 has a proximal opening into which the transducer horn 78 may be inserted to engage the sonic connector 76. A distal bore 88 is provided at the distal end of the catheter knob 20, with the distal bore 88 communicating with the proximal bore 84 via a channel 90. The sonic connector 76 has a front shaft 94 extending distally from a central portion 92. The sonic connector 76 also has a threaded stem 96 extending proximally from the central portion 92 to permit the distal end of the transducer horn 78 to be threadably screwed onto and removably attached to the sonic connector 76. The proximal end of the Y-connector 18 can be threadably engaged to the distal opening of the distal bore 88.
The distal end of the front shaft 94 has an inner bore (not shown) that terminates before the central portion 92. The proximal portion of the ultrasound transmission wire 42 extends through the channel 90 in the knob 20 and through the bores 84 and 88, and the proximal-most region 421 is dimensioned to be snugly fitted inside the inner bore of the front shaft 94. The proximal-most region 421 of the ultrasound transmission wire 42 is secured inside the inner bore of the front shaft 94 by welding, bonding, crimping, soldering, or other conventional attachment mechanisms.
A first absorber 98 is seated in the distal bore 88 and itself defines a bore that receives (i.e., circumferentially surrounds) the ultrasound transmission wire 42. In other words, the absorber 98 is positioned between the ultrasound transmission wire 42 and the bore 88. The absorber 98 can be made of an elastic material, and non- limiting examples include a polymer or rubber. Alternatively, the absorber 98 can be provided in the form of O-rings. The absorber 98 functions to absorb transverse micro-motions, thereby minimizing the undesirable transverse vibrations.
The sonic connector 76 can be provided with a partial thread and a flat proximal surface, which are important to providing a firm connection between the transducer horn 78 and the sonic connector 76. Specifically, referring to
The present invention provides an ultrasound transmission wire 42 having a configuration that improves the delivery of ultrasound energy to the distal head 44 while minimizing stress and fatigue at the connection of the ultrasound transmission wire 42 to the sonic connector 76. In particular, the ultrasound transmission wire 42 of the present invention provides a proximal-most end that is connected with the sonic connector 76, with this proximal-most end having a greater diameter than the rest of the ultrasound transmission wire 42.
The ultrasound transmission wire 42 has a first proximal-most region 421, a second region 422 that extends distally from the distal end of the first region 421, a third region 423 that extends distally from the distal end of the second region 422, a fourth region 424 that extends distally from the distal end of the third region 423, a fifth region 425 that extends distally from the distal end of the fourth region 424, a sixth region 426 that extends distally from the distal end of the fifth region 425, and a seventh distal-most region 427 that extends distally from the distal end of the sixth region 426. As best shown in
The first proximal-most region 421 is adapted to be attached to the sonic connector 76, which is in turn attached to the transducer 24. The first region 421 has a length that ranges between 0.005 and 5 inches, but is preferably between 0.01 and 0.5 inches. The first region 421 has a cross-sectional outer diameter that ranges between 0.01 and 0.06 inches, but is preferably between 0.035 and 0.045 inches. The third region 423 has a cross-sectional outer diameter that ranges between 0.02 and 0.05 inches, but is preferably about 0.030 inches. The third region 423 has a length that ranges between 20 to 140 cm, and preferably about 100 cm.
The significance of a larger-diameter proximal-most region 421 that is adapted to connect to the sonic connector 76 is as follows. The difference between the dimensions of the ultrasound transmission wire 42 and the horn of the transducer 24 creates a dimensional step which causes a large amplification of propagated ultrasound energy from the transducer 24 via the sonic connector 76 to the ultrasound transmission wire 42. In fact, both the transverse and longitudinal motions produced by the transducer 24 will be amplified by this dimensional step. In particular, the transverse motions create significant stress at the connection area between the ultrasound transmission wire 42 and the transducer 24. As a result, a smaller ultrasound transmission wire 42 (i.e., having a smaller diameter) would be more susceptible to breakage at the connection area. However, providing a larger-diameter ultrasound transmission wire 42 would not be feasible. For example, the proximal 10 to 20 inches of the ultrasound transmission wire 42 will typically be outside the patient during an interventional procedure, and this proximal portion is often subjected to bends while a physician handles the catheter 10. These bends would cause a larger-diameter ultrasound transmission wire 42 to experience greater acoustical losses than a smaller-diameter ultrasound transmission wire 42. As a result of these considerations, the present invention provides a novel configuration for the ultrasound transmission wire 42 where (I) the proximal-most region 421 has the greatest diameter to minimize breakage at the connection area, (ii) portions of the intermediate region 428 (e.g., the region 425) have the smallest diameter to improve propagation of ultrasound energy, and (iii) the distal regions 426, 427 have a greater diameter than the intermediate region 428 to facilitate greater efficiency in the transmission of ultrasound energy from the ultrasound transmission wire 42, to improve the strength of the ultrasound transmission wire 42, and to minimize breakage of the ultrasound transmission wire 42. In particular, increasing the cross-section of the ultrasound transmission wire 42 at its distal end provides a larger cross-sectional area to tolerate stress associated with the attachment of distal-most region 427 to the distal head 44.
The tapering in some of the regions (e.g., 423, 424, 425, 426) provides a continuous and smooth transition for the amplification of ultrasound energy without steps, which helps improve the stability of the ultrasound transmission wire 42.
The present invention also provides the use of microbubbles to enhance the cavitational effect and improve the ultrasound ablation. According to the present invention, microbubbles 66 (see
The microbubbles 66, 66a improve the cavitational effect. In particular, the reciprocating movement of the distal tip 46 of the catheter 10 in a fluid (i.e., blood) creates cavities or bubbles to create a transitory phenomenon or mechanical effect called cavitation. It produces an instantaneous stress estimated at many thousands of atmospheres, and a significantly higher temperature within a cavitation threshold, at a very small area in front of the distal tip 46. If the catheter is placed against atherosclerotic material, this cavitation will cause ablation of the material. Adding microbubbles 66, 66a in front of the distal tip 46 where cavitation is taking place will increase the number of bubbles at the distal tip 46, thereby enhancing cavitation. In other words, the introduction of additional microbubbles increases the cavitational effect without changing or adding to the construction of the catheter 10.
Thus, the ultrasound system according to present invention provides structural components that address two of the general problems encountered by the known ultrasound systems and devices. For instance, effective transmission of ultrasound energy is achieved by the novel transmission wire 42 and the sonic connector 76. In addition, the transmission wire 42 is cooled by the refrigerated coolant fluid and the use of microbubbles. Further, the introduction of microbubbles to the distal tip 46 of the catheter 10 enhances cavitation.
While the description above refers to particular embodiments of the present invention, it will be understood that many modifications may be made without departing from the spirit thereof. The accompanying claims are intended to cover such modifications as would fall within the true scope and spirit of the present invention.
Number | Name | Date | Kind |
---|---|---|---|
3433226 | Boyd | Mar 1969 | A |
3565062 | Kuris | Feb 1971 | A |
3612038 | Halligan | Oct 1971 | A |
3631848 | Muller | Jan 1972 | A |
3719737 | Vaillancourt et al. | Mar 1973 | A |
3823717 | Pohlman et al. | Jul 1974 | A |
3839841 | Amplatz | Oct 1974 | A |
3896811 | Storz | Jul 1975 | A |
4016882 | Broadwin et al. | Apr 1977 | A |
4033331 | Guss et al. | Jul 1977 | A |
4136700 | Broadwin et al. | Jan 1979 | A |
4337090 | Harrison | Jun 1982 | A |
4368410 | Hance | Jan 1983 | A |
4417578 | Banko | Nov 1983 | A |
4425115 | Wuchinich | Jan 1984 | A |
4486680 | Bonnet et al. | Dec 1984 | A |
4505767 | Quin | Mar 1985 | A |
4565589 | Harrison | Jan 1986 | A |
4572184 | Stohl et al. | Feb 1986 | A |
4664112 | Kensey et al. | May 1987 | A |
4665906 | Jervis | May 1987 | A |
4679558 | Kensey et al. | Jul 1987 | A |
4700705 | Kensey et al. | Oct 1987 | A |
4721117 | Mar et al. | Jan 1988 | A |
4750902 | Wuchinich et al. | Jun 1988 | A |
4808153 | Parisi | Feb 1989 | A |
4811743 | Stevens | Mar 1989 | A |
4827911 | Broadwin et al. | May 1989 | A |
4838853 | Parisi | Jun 1989 | A |
4854325 | Stevens | Aug 1989 | A |
4870953 | DonMicheal et al. | Oct 1989 | A |
4886060 | Wiksell | Dec 1989 | A |
4920954 | Alliger et al. | May 1990 | A |
4923462 | Stevens | May 1990 | A |
4924863 | Sterzer | May 1990 | A |
4931047 | Broadwin et al. | Jun 1990 | A |
4936281 | Stasz | Jun 1990 | A |
4936845 | Stevens | Jun 1990 | A |
5000185 | Yock | Mar 1991 | A |
5015227 | Broadwin et al. | May 1991 | A |
5026384 | Farr et al. | Jun 1991 | A |
5046503 | Schneiderman | Sep 1991 | A |
5053008 | Bajaj | Oct 1991 | A |
5058570 | Idemoto et al. | Oct 1991 | A |
5076276 | Sakurai | Dec 1991 | A |
5091205 | Fan | Feb 1992 | A |
5100423 | Fearnot | Mar 1992 | A |
5109859 | Jenkins | May 1992 | A |
5114414 | Buchbinder | May 1992 | A |
5116350 | Stevens | May 1992 | A |
5127917 | Niederhauser et al. | Jul 1992 | A |
5156143 | Bocquet et al. | Oct 1992 | A |
5163421 | Bernstein | Nov 1992 | A |
5180363 | Idemoto et al. | Jan 1993 | A |
5183470 | Wettermann | Feb 1993 | A |
5195955 | Don Michael | Mar 1993 | A |
5215614 | Wijkamp et al. | Jun 1993 | A |
5221255 | Mahurkar et al. | Jun 1993 | A |
5226421 | Frisbie et al. | Jul 1993 | A |
5234416 | Macaulay et al. | Aug 1993 | A |
5238004 | Sahatjian et al. | Aug 1993 | A |
5242385 | Strukel | Sep 1993 | A |
5243997 | Uflacker et al. | Sep 1993 | A |
5248296 | Alliger | Sep 1993 | A |
5255669 | Kubota et al. | Oct 1993 | A |
5267954 | Nita | Dec 1993 | A |
5269291 | Carter | Dec 1993 | A |
5269297 | Weng et al. | Dec 1993 | A |
5269793 | Simpson | Dec 1993 | A |
5287858 | Hammerslag et al. | Feb 1994 | A |
5290229 | Paskar | Mar 1994 | A |
5304115 | Pflueger et al. | Apr 1994 | A |
5304131 | Paskar | Apr 1994 | A |
5312328 | Nita et al. | May 1994 | A |
5318014 | Carter | Jun 1994 | A |
5318570 | Hood et al. | Jun 1994 | A |
5324255 | Passafaro et al. | Jun 1994 | A |
5324260 | O'Neill et al. | Jun 1994 | A |
5325860 | Seward et al. | Jul 1994 | A |
5326342 | Pflueger et al. | Jul 1994 | A |
5341818 | Abrams et al. | Aug 1994 | A |
5342292 | Nita et al. | Aug 1994 | A |
5344395 | Whalen et al. | Sep 1994 | A |
5346502 | Estabrook et al. | Sep 1994 | A |
5362309 | Carter | Nov 1994 | A |
5368557 | Nita | Nov 1994 | A |
5368558 | Nita | Nov 1994 | A |
5376084 | Bacich et al. | Dec 1994 | A |
5378234 | Hammerslag et al. | Jan 1995 | A |
5380274 | Nita | Jan 1995 | A |
5380316 | Aita et al. | Jan 1995 | A |
5382228 | Nita et al. | Jan 1995 | A |
5383460 | Jang et al. | Jan 1995 | A |
5389096 | Aita et al. | Feb 1995 | A |
5397293 | Alliger et al. | Mar 1995 | A |
5397301 | Pflueger et al. | Mar 1995 | A |
5405318 | Nita | Apr 1995 | A |
5409483 | Campbell et al. | Apr 1995 | A |
5417672 | Nita et al. | May 1995 | A |
5417703 | Brown et al. | May 1995 | A |
5421923 | Clarke et al. | Jun 1995 | A |
5427118 | Nita et al. | Jun 1995 | A |
5431168 | Webster, Jr. | Jul 1995 | A |
5431663 | Carter | Jul 1995 | A |
5443078 | Uflacker | Aug 1995 | A |
5447509 | Mills et al. | Sep 1995 | A |
5449369 | Imran | Sep 1995 | A |
5451209 | Ainsworth et al. | Sep 1995 | A |
5465733 | Hinohara et al. | Nov 1995 | A |
5474531 | Carter | Dec 1995 | A |
5480379 | La Rosa | Jan 1996 | A |
5484398 | Stoddard | Jan 1996 | A |
5487757 | Truckai et al. | Jan 1996 | A |
5507738 | Ciervo | Apr 1996 | A |
5516043 | Manna et al. | May 1996 | A |
5527273 | Manna et al. | Jun 1996 | A |
5540656 | Pflueger et al. | Jul 1996 | A |
5542917 | Nita et al. | Aug 1996 | A |
5597882 | Schiller et al. | Jan 1997 | A |
5607421 | Jeevanandam et al. | Mar 1997 | A |
5611807 | O'Boyle | Mar 1997 | A |
5618266 | Liprie | Apr 1997 | A |
5626593 | Imran | May 1997 | A |
5649935 | Kremer et al. | Jul 1997 | A |
5658282 | Daw et al. | Aug 1997 | A |
5695460 | Siegel et al. | Dec 1997 | A |
5695507 | Auth et al. | Dec 1997 | A |
5715825 | Crowley | Feb 1998 | A |
5720724 | Ressemann et al. | Feb 1998 | A |
5728062 | Brisken | Mar 1998 | A |
5738100 | Yagami et al. | Apr 1998 | A |
5797876 | Spears et al. | Aug 1998 | A |
5816923 | Milo et al. | Oct 1998 | A |
5827203 | Nita | Oct 1998 | A |
5830222 | Makower | Nov 1998 | A |
5846218 | Brisken et al. | Dec 1998 | A |
5895397 | Jang et al. | Apr 1999 | A |
5902287 | Martin | May 1999 | A |
5904667 | Falwell | May 1999 | A |
5935142 | Hood | Aug 1999 | A |
5935144 | Estabrook | Aug 1999 | A |
5944737 | Tsonton et al. | Aug 1999 | A |
5957882 | Nita et al. | Sep 1999 | A |
5957899 | Spears et al. | Sep 1999 | A |
5964223 | Baran | Oct 1999 | A |
5967984 | Chu et al. | Oct 1999 | A |
5971949 | Levin et al. | Oct 1999 | A |
5976119 | Spears et al. | Nov 1999 | A |
5989208 | Nita | Nov 1999 | A |
5997497 | Nita et al. | Dec 1999 | A |
6004280 | Buck et al. | Dec 1999 | A |
6007499 | Martin et al. | Dec 1999 | A |
6007514 | Nita | Dec 1999 | A |
6022309 | Celliers et al. | Feb 2000 | A |
6029671 | Stevens et al. | Feb 2000 | A |
6030357 | Daoud et al. | Feb 2000 | A |
6051010 | DiMatteo et al. | Apr 2000 | A |
6113558 | Rosenschein et al. | Sep 2000 | A |
6123698 | Spears et al. | Sep 2000 | A |
6149596 | Bancroft | Nov 2000 | A |
6159176 | Broadwin et al. | Dec 2000 | A |
6165127 | Crowley | Dec 2000 | A |
6165188 | Saadat et al. | Dec 2000 | A |
6179809 | Khairkhahan et al. | Jan 2001 | B1 |
6190353 | Makower et al. | Feb 2001 | B1 |
6206842 | Tu et al. | Mar 2001 | B1 |
6210356 | Anderson et al. | Apr 2001 | B1 |
6217543 | Anis et al. | Apr 2001 | B1 |
6231546 | Milo et al. | May 2001 | B1 |
6231587 | Makower | May 2001 | B1 |
6235007 | Divino, Jr. et al. | May 2001 | B1 |
6241692 | Tu et al. | Jun 2001 | B1 |
6241703 | Levin et al. | Jun 2001 | B1 |
6277084 | Abele et al. | Aug 2001 | B1 |
6283983 | Makower et al. | Sep 2001 | B1 |
6287271 | Dubrul et al. | Sep 2001 | B1 |
6287285 | Michal et al. | Sep 2001 | B1 |
6287317 | Makower et al. | Sep 2001 | B1 |
6296620 | Gesswein et al. | Oct 2001 | B1 |
6302875 | Makower et al. | Oct 2001 | B1 |
6309358 | Okubo | Oct 2001 | B1 |
6315741 | Martin et al. | Nov 2001 | B1 |
6379378 | Werneth et al. | Apr 2002 | B1 |
6387109 | Davison et al. | May 2002 | B1 |
6394956 | Chandrasekaran et al. | May 2002 | B1 |
6398736 | Seward | Jun 2002 | B1 |
6416533 | Gobin et al. | Jul 2002 | B1 |
6423026 | Gesswein et al. | Jul 2002 | B1 |
6433464 | Jones | Aug 2002 | B2 |
6434418 | Neal et al. | Aug 2002 | B1 |
6450975 | Brennan et al. | Sep 2002 | B1 |
6454757 | Nita et al. | Sep 2002 | B1 |
6454997 | Divino, Jr. et al. | Sep 2002 | B1 |
6484052 | Visuri et al. | Nov 2002 | B1 |
6491707 | Makower | Dec 2002 | B2 |
6494891 | Cornish et al. | Dec 2002 | B1 |
6508781 | Brennan et al. | Jan 2003 | B1 |
6508784 | Shu | Jan 2003 | B1 |
6511458 | Milo et al. | Jan 2003 | B2 |
6524251 | Rabiner et al. | Feb 2003 | B2 |
6544215 | Bencini et al. | Apr 2003 | B1 |
6547754 | Evans et al. | Apr 2003 | B1 |
6551337 | Rabiner et al. | Apr 2003 | B1 |
6554846 | Hamilton et al. | Apr 2003 | B2 |
6558502 | Divino, Jr. et al. | May 2003 | B2 |
6562031 | Chandrasekaran et al. | May 2003 | B2 |
6589253 | Cornish et al. | Jul 2003 | B1 |
6596235 | Divino, Jr. et al. | Jul 2003 | B2 |
6615062 | Ryan et al. | Sep 2003 | B2 |
6623448 | Slater | Sep 2003 | B2 |
6635017 | Moehring et al. | Oct 2003 | B1 |
6650923 | Lesh et al. | Nov 2003 | B1 |
6652547 | Rabiner et al. | Nov 2003 | B2 |
6660013 | Rabiner | Dec 2003 | B2 |
6676900 | Divino, Jr. et al. | Jan 2004 | B1 |
6685657 | Jones | Feb 2004 | B2 |
6689086 | Nita et al. | Feb 2004 | B1 |
6695781 | Rabiner et al. | Feb 2004 | B2 |
6695782 | Ranucci et al. | Feb 2004 | B2 |
6695810 | Peacock, III et al. | Feb 2004 | B2 |
6702748 | Nita et al. | Mar 2004 | B1 |
6702750 | Yock | Mar 2004 | B2 |
6719725 | Milo et al. | Apr 2004 | B2 |
6729334 | Baran | May 2004 | B1 |
6733451 | Rabiner et al. | May 2004 | B2 |
6761698 | Shibata et al. | Jul 2004 | B2 |
6855123 | Nita | Feb 2005 | B2 |
6866670 | Rabiner et al. | Mar 2005 | B2 |
6896659 | Conston et al. | May 2005 | B2 |
6936025 | Evans et al. | Aug 2005 | B1 |
6936056 | Nash et al. | Aug 2005 | B2 |
6942620 | Nita et al. | Sep 2005 | B2 |
6942677 | Nita et al. | Sep 2005 | B2 |
7004173 | Sparks et al. | Feb 2006 | B2 |
7056294 | Khairkhahan et al. | Jun 2006 | B2 |
7131983 | Murakami | Nov 2006 | B2 |
7137963 | Nita et al. | Nov 2006 | B2 |
7150853 | Lee et al. | Dec 2006 | B2 |
7166098 | Steward et al. | Jan 2007 | B1 |
7220233 | Nita et al. | May 2007 | B2 |
7267650 | Chow et al. | Sep 2007 | B2 |
7335180 | Nita et al. | Feb 2008 | B2 |
7341569 | Soltani et al. | Mar 2008 | B2 |
7384407 | Rodriguez et al. | Jun 2008 | B2 |
7494468 | Rabiner et al. | Feb 2009 | B2 |
7503895 | Rabiner et al. | Mar 2009 | B2 |
7540852 | Nita et al. | Jun 2009 | B2 |
7604608 | Nita et al. | Oct 2009 | B2 |
7621929 | Nita et al. | Nov 2009 | B2 |
7776025 | Bobo, Jr. | Aug 2010 | B2 |
7938819 | Kugler et al. | May 2011 | B2 |
7955293 | Nita et al. | Jun 2011 | B2 |
8043251 | Nita et al. | Oct 2011 | B2 |
8083727 | Kugler et al. | Dec 2011 | B2 |
8226566 | Nita | Jul 2012 | B2 |
20020107473 | Bond et al. | Aug 2002 | A1 |
20030009153 | Brisken et al. | Jan 2003 | A1 |
20030036705 | Hare et al. | Feb 2003 | A1 |
20030125620 | Satou et al. | Jul 2003 | A1 |
20030199817 | Thompson et al. | Oct 2003 | A1 |
20030216732 | Truckai et al. | Nov 2003 | A1 |
20030225332 | Okada et al. | Dec 2003 | A1 |
20040138563 | Moehring et al. | Jul 2004 | A1 |
20040204670 | Nita et al. | Oct 2004 | A1 |
20050215946 | Hansmann et al. | Sep 2005 | A1 |
20050222557 | Baxter et al. | Oct 2005 | A1 |
20050228286 | Messerly et al. | Oct 2005 | A1 |
20060264759 | Moehring et al. | Nov 2006 | A1 |
20060264809 | Hansmann et al. | Nov 2006 | A1 |
20070037119 | Pal et al. | Feb 2007 | A1 |
20070260172 | Nita | Nov 2007 | A1 |
20080108937 | Nita | May 2008 | A1 |
20080208109 | Soltani et al. | Aug 2008 | A1 |
20080221506 | Rodriguez et al. | Sep 2008 | A1 |
20080228111 | Nita | Sep 2008 | A1 |
20110130834 | Wilson et al. | Jun 2011 | A1 |
Number | Date | Country |
---|---|---|
2256127 | May 1974 | DE |
2438648 | Feb 1976 | DE |
3821836 | Jan 1990 | DE |
8910040 | Jan 1990 | DE |
4042435 | Aug 1991 | DE |
0005719 | Dec 1979 | EP |
0316789 | May 1989 | EP |
0376562 | Jul 1990 | EP |
0379156 | Jul 1990 | EP |
0394583 | Oct 1990 | EP |
0443256 | Aug 1991 | EP |
0541249 | May 1993 | EP |
0820728 | Jan 1998 | EP |
1323481 | Jul 2003 | EP |
1106957 | Mar 1968 | GB |
01099547 | Apr 1989 | JP |
2-71510 | May 1990 | JP |
U03067608 | Jul 1991 | JP |
2006086822 | Mar 1994 | JP |
2007116260 | May 1995 | JP |
10216140 | Aug 1998 | JP |
2001104356 | Apr 2001 | JP |
2001321388 | Nov 2001 | JP |
2002186627 | Jul 2002 | JP |
2005-253874 | Sep 2005 | JP |
WO8906515 | Jul 1989 | WO |
9001300 | Feb 1990 | WO |
9004362 | May 1990 | WO |
9107917 | Jun 1991 | WO |
WO9211815 | Jul 1992 | WO |
WO9308750 | May 1993 | WO |
9316646 | Sep 1993 | WO |
WO9412140 | Jun 1994 | WO |
9414382 | Jul 1994 | WO |
WO9508954 | Apr 1995 | WO |
WO9509571 | Apr 1995 | WO |
WO 9515192 | Jun 1995 | WO |
WO9635469 | Nov 1996 | WO |
WO 9721462 | Jun 1997 | WO |
WO9745078 | Dec 1997 | WO |
WO 9852637 | Nov 1998 | WO |
WO9925412 | May 1999 | WO |
WO0053341 | Sep 2000 | WO |
WO0067830 | Nov 2000 | WO |
WO2004012609 | Feb 2004 | WO |
WO 2004112888 | Dec 2004 | WO |
WO 2006049593 | May 2006 | WO |
Entry |
---|
http://www.merriam-webster.com/dictionary/couple, definition of the term coupled retrieved on May 18, 2013. |
http://www.thefreedictionary.com/connected, retrieved on Sep. 21, 2013. |
Siegel, et al., “In Vivo Ultrasound Arterial Recanalization of Atherosclerotic Total Occlusions”, Journal of the American College of Cardiology, Feb. 1990, vol. 15, No. 2, pp. 345-351. |
Extended European Search Report dated Mar. 5, 2012 for European Application No. 12153606.4. |
Health Care Without Harm [report], Non-Incineration Medical Waste Treatment Technologies, “Irradiation, biological, and other technologies: E-beam, biological, and sharps treatment systems”, Chapter 9., Aug. 2001, pp. 69-74. |
Chandra Sehgal et al., Ultrasound-Assisted Thrombolysis, Investigative Radiology, 1993, vol. 28, Issue 10, pp. 939-943. |
http://www.merriam-webster.com/dictionary/couple, definition of the term coupled retrieved on, May 18, 2013. |
Margaret Fyfe et al., Mast cell degranulation and increased vascular permeability induced by ‘therapeutic’ ultrasound in the rate ankle joint, Br. J. exp. Path., 1984, vol. 65, pp. 671-676. |
Number | Date | Country | |
---|---|---|---|
20070239027 A1 | Oct 2007 | US |